Vivani Medical Secures $3.9M in Combined Offering, Director Gregg Williams Participates
VANI sits 58% above its 52-week low of $0.905 on elevated volume (3.0× avg).
Summary
Vivani Medical finalized a registered direct offering and concurrent private placement, raising $3.9 million, with Director Gregg Williams purchasing a substantial stake.
Key Events · Financing and Capital Events · VANI
-
Public Offering Finalized
Vivani Medical is offering 1,689,200 shares of common stock at $1.48 per share in a registered direct offering, generating approximately $2.0 million in net proceeds.
-
Director Participates in Concurrent Private Placement
Director and 10% owner Gregg Williams agreed to purchase 1,351,351 shares of common stock at $1.48 per share in a concurrent private placement, contributing approximately $1.9 million in net proceeds. This follows a reported significant purchase on January 20, 2026.
-
Total Capital Raised
The combined offerings are expected to yield approximately $3.9 million in net proceeds for the company.
-
Use of Proceeds and Runway
Proceeds will fund research and clinical development of pipeline candidates, working capital, capital expenditures, and general corporate purposes, extending the company's cash runway into mid-2027.
Analysis · VANI · Industrial Applications And Services
This 424B5 filing finalizes the terms and pricing of a registered direct offering and a concurrent private placement, raising approximately $3.9 million in net proceeds. The offering, priced at $1.48 per share, includes a substantial purchase of 1,351,351 shares by Director and 10% owner Gregg Williams in a concurrent private placement. This insider participation, following a previously reported significant purchase on January 20, 2026, signals strong confidence from a key stakeholder. While the offering is dilutive for new investors, the capital infusion is crucial for Vivani Medical, a clinical-stage biopharmaceutical company, extending its operational runway into mid-2027 and funding ongoing research and clinical development.
How filings like this one have moved
In the 30 days to Sep 15, 2026, 29.9% of the 1678 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.25%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, VANI was trading at $1.43 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $100.7M. The 52-week trading range was $0.91 to $1.92. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.